Picture of PMGC Holdings logo

ELAB PMGC Holdings Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Momentum

Relative Strength (%)
1m-54.34%
3m-88.67%
6m-98.32%
1yr-99.78%
Volume Change (%)
10d/3m+53.52%
Price vs... (%)
52w High-99.79%
50d MA-60.77%
200d MA-98.58%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-50.93%
Return on Equity-76.61%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of PMGC Holdings EPS forecast chart

Profile Summary

PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. The Company’s portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is a research and development subsidiary of the Company, which is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment vehicle engaging in investing, lending, and seeking diversified investment opportunities across various markets.

Directors

    Last Annual
    December 31st, 2024
    Last Interim
    December 31st, 2024
    Incorporated
    November 22nd, 2024
    Public Since
    November 21st, 2023
    No. of Shareholders
    47
    No. of Employees
    2
    Sector
    Healthcare Providers & Services
    Industry
    Healthcare
    Exchange
    us flag iconNASDAQ Capital Market
    Shares in Issue
    884,381

    ELAB Share Price Performance

    Similar to ELAB

    Picture of ADVANCED BIOMED logo

    ADVANCED BIOMED

    us flag iconNASDAQ Capital Market

    Picture of IMEI Technology Health logo

    IMEI Technology Health

    us flag iconNASDAQ Capital Market

    Picture of Akanda logo

    Akanda

    us flag iconNASDAQ Capital Market

    Picture of Astrana Health logo

    Astrana Health

    us flag iconNASDAQ Capital Market

    Picture of Basel Medical logo

    Basel Medical

    us flag iconNASDAQ Capital Market

    FAQ